EPA and DHA come under the category of omega-3 fatty acids that are mainly obtained from marine sources. These fatty acids provide various health benefits such as improving brain and cardiovascular health. They have anti-inflammatory properties and help improve metabolism. EPA and DHA find applications in food and beverages, pharmaceuticals, and nutraceuticals. The nutraceutical segment accounts for the largest share due to increasing consumer awareness about health and wellness.

The Global EPA and DHA Market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the EPA and DHA market are KHS GmbH, Tetra Pak International SA (Tetra Laval Group), Syntegon Technology GmbH, JBT Corporation, GEA Group Aktiengesellschaft, Sidel Group (Tetra Laval Group), Krones AG, Ronchi Mario SPA, Coesia Group, and Barry-Wehmiller Companies Inc. The nutraceutical segment dominates market demand due to numerous health benefits provided by EPA and DHA in the prevention and treatment of various diseases. North America currently holds the largest share in the EPA and DHA market owing to increased consumption of dietary supplements, functional foods, and beverages coupled with rising health-consciousness across Canada and the US. The market is witnessing high growth in the Asia Pacific region driven by growing population, increasing disposable incomes, and increasing consumer awareness about health and wellness.

Market Drivers

The demand for EPA And DHA Market Size is driven by growing usage of nutraceuticals globally. With increasing health issues like obesity, cardiovascular diseases, and hypertension, consumers are focusing more on preventive healthcare and incorporating dietary supplements rich in omega-3 fatty acids. EPA and DHA provide anti-inflammatory and cardiovascular benefits helping manage various lifestyle diseases. The rising application of these fatty acids in infant formula is another key factor fueling market growth as it aids brain and eye development in infants. Manufacturers are launching novel formulations of EPA and DHA to capture larger market share.